Aristotle Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
165,570
+6,704
| +4% | +$711K | 0.03% | 126 |
|
|
2025
Q1 | $19.7M | Sell |
158,866
-37,072
| -19% | -$4.6M | 0.04% | 120 |
|
|
2024
Q4 | $24.1M | Sell |
195,938
-16,753
| -8% | -$2.06M | 0.05% | 124 |
|
|
2024
Q3 | $23.7M | Buy |
212,691
+15,455
| +8% | +$1.72M | 0.04% | 124 |
|
|
2024
Q2 | $21.1M | Buy |
197,236
+293
| +0.1% | +$31.3K | 0.04% | 124 |
|
|
2024
Q1 | $23.7M | Sell |
196,943
-261
| -0.1% | -$31.4K | 0.04% | 123 |
|
|
2023
Q4 | $24.3M | Buy |
197,204
+21,447
| +12% | +$2.64M | 0.05% | 119 |
|
|
2023
Q3 | $22.7M | Buy |
+175,757
| New | +$22.7M | 0.05% | 117 |
|